Company Filing History:
Years Active: 2018
Title: Jinglong Jiang: Innovator in Renal Pharmacology
Introduction
Jinglong Jiang is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of renal pharmacology, particularly through his innovative work on potassium channel inhibitors.
Latest Patents
Jinglong Jiang holds 1 patent for his invention titled "Inhibitors of the renal outer medullary potassium channel." This patent presents compounds of Formula I and their pharmaceutically acceptable salts, which act as inhibitors of the ROMK (Kir1.1) channel. The compounds are designed for use as diuretic and/or natriuretic agents, addressing medical conditions such as cardiovascular diseases, including hypertension, heart failure, and chronic kidney disease, as well as conditions associated with excessive salt and water retention.
Career Highlights
Jinglong Jiang is currently employed at Merck Sharp & Dohme Corp., where he continues to advance his research and development efforts in pharmacology. His work has the potential to significantly impact the treatment of various medical conditions.
Collaborations
Throughout his career, Jinglong has collaborated with esteemed colleagues, including Alexander Pasternak and Ian W. Davies. These partnerships have fostered a productive environment for innovation and discovery.
Conclusion
Jinglong Jiang's contributions to renal pharmacology through his innovative patent demonstrate his commitment to improving medical therapies. His work continues to pave the way for advancements in the treatment of cardiovascular and renal conditions.